Urinary excretion of bile acids in bile duct-ligated rats

被引:0
|
作者
Yukiko Takada
Naoyo Sano
Hajime Takikawa
机构
[1] Department of Medicine,
[2] Teikyo University School of Medicine,undefined
[3] Itabashi-ku,undefined
[4] Tokyo 173-8605,undefined
[5] Japan,undefined
来源
关键词
Key words: bile acid, bile duct ligation, cholestasis, jaundice, urinary excretion;
D O I
暂无
中图分类号
学科分类号
摘要
In patients with complete bile duct obstruction, the only pathway of bile acid elimination is through the urine. However, the urinary excretion of various bile acid conjugates in the presence of bile duct obstruction has not been clarified. Given this factor, the urinary excretion of various bile acids was compared in rats that were bile duct-ligated for 3 days. Methods. After urinary bladder cannulation, radiolabeled bile acids were intravenously injected, and urine samples were collected every 2 h for 6 h, and radioactivity was counted. Results. Urinary excretion (cumulative percent dose during 6 h) of taurocholate and cholate was similar (19.3% and 16.8%). Urinary excretion of tauroursodeoxycholate, lithocholate, and taurolithocholate-sulfate was less effective (12.7%, 9.8% and 2.1%, respectively). Cholate was mostly conjugated with taurine, and lithocholate was mostly conjugated with taurine and further hydroxylated. Conclusions. These results indicate that unconjugated bile acids were taken up by the liver and excreted into the blood after further biotransformation even under conditions of complete bile duct obstruction. Although bile acid sulfates are the major bile acids in the urine of patients with obstructive jaundice, monohydroxylated bile acids are considered not to be so effectively excreted into the urine, even with conjugation with taurine and sulfate, in rats.
引用
收藏
页码:561 / 566
页数:5
相关论文
共 50 条
  • [1] Urinary excretion of bile acids in bile duct-ligated rats
    Takada, Y
    Sano, N
    Takikawa, H
    JOURNAL OF GASTROENTEROLOGY, 2003, 38 (06) : 561 - 566
  • [2] Urinary excretion of cholephilic compounds in bile duct-ligated rats.
    Takada, Y
    Tanaka, H
    Hojo, M
    Takeuchi, A
    Marumo, T
    Hanawa, N
    Tachizawa, H
    Kurihara, H
    Takayanagi, M
    Sasamoto, T
    Akashi, M
    Aiso, M
    Takamori, Y
    Sano, N
    Takikawa, H
    HEPATOLOGY, 2002, 36 (04) : 455A - 455A
  • [3] Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR)
    Takada, Y
    Tachizawa, H
    Kurihara, H
    Takayanagi, M
    Sasamoto, T
    Akashi, M
    Aiso, M
    Takamori, Y
    Sano, N
    Takikawa, H
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2004, 11 (02): : 125 - 128
  • [4] PHOTOTHERAPY IN BILE DUCT-LIGATED GUNN-RATS
    BALLOWITZ, L
    MULLER, WHW
    WIESE, G
    BIOLOGICAL RESEARCH IN PREGNANCY AND PERINATOLOGY, 1984, 5 (01): : 36 - 41
  • [5] Responsibility of thoracic aorta in bile duct-ligated rats
    Murakami, R
    Uchida, M
    Honda, H
    Kogo, H
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 256P - 256P
  • [6] Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats
    Mottino, Aldo D.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (03) : 475 - 480
  • [7] Induction of arginase II in livers of bile duct-ligated rats
    Wei, CL
    Hon, WM
    Lee, KH
    Mori, M
    Gotoh, T
    Khoo, HE
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (06) : 1043 - 1050
  • [8] Time course of collagen peak in bile duct-ligated rats
    Orhan Tarcin
    Metin Basaranoglu
    Veysel Tahan
    Gülgün Tahan
    Ilker Sücüllü
    Nevin Yilmaz
    Gagan Sood
    Ned Snyder
    Gilbert Hilman
    Cigdem Celikel
    Nurdan Tözün
    BMC Gastroenterology, 11
  • [9] EXPRESSION OF METALLOPROTEINASES AND THEIR INHIBITORS (TIMPS) IN BILE DUCT-LIGATED RATS
    PHILLIPS, B
    LEE, SS
    ZHANG, Y
    KOSSAKOWSKA, AE
    URBANSKI, SJ
    HEPATOLOGY, 1995, 22 (04) : 1054 - 1054
  • [10] Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats
    Yi, En-tong
    Liu, Rui-xia
    Wen, Yan
    Yin, Cheng-hong
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (12) : 1518 - 1524